Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.

Related Articles

Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.

Nucl Med Commun. 2018 Apr 11;:

Authors: Chiaravalloti A, Barbagallo G, Ricci M, Sannino P, Karalis G, Ursini F, Schillaci O

Abstract
BACKGROUND: The aim of this study was to investigate the relationship between age and uptake of fluorine-18-L-dihydroxyphenylalanine (F-DOPA) in the brain and myocardial uptake of iodine-123-metaiodobenzylguanidine (I-MIBG) in normal adult participants.
PARTICIPANTS AND METHODS: To this end, a total of 72 healthy participants were enroled. Of these, 37 individuals (male, 21; female, 16; mean age: 60±12 years; age range: 38-85 years) underwent F-DOPA PET/CT, whereas 35 individuals (male, 19; female, 16; mean age: 61±17 years; age range: 17-87 years) underwent I-MIBG scintigraphy. For F-DOPA PET/CT, regions of interest were placed on the caudate nucleus, globus pallidus and putamen by means of the WFU Pickatlas tool implemented in SPM8 and further analysed after a normalization process. For I-MIBG scintigraphy, regions of interest were set over the upper mediastinum and a heart-to-mediastinum count ratio was calculated. The relation between age and normalized F-DOPA values or heart-to-mediastinum ratio values was examined using correlation analysis of variance and Pearson's correlation coefficient.
RESULTS: We did not find any significant relationship between age and F-DOPA and I-MIBG uptake, respectively.
CONCLUSION: Our findings suggest that both brain F-DOPA PET/CT and cardiac I-MIBG scintigraphy represent age-independent biomarkers whose analyses of quantitative uptake may not require adjustment for patients' age.

PMID: 29649065 [PubMed - as supplied by publisher]

https://ift.tt/2vidFvi